TD Cowen analyst Stacy Ku maintained a Buy rating on scPharmaceuticals (SCPH – Research Report) yesterday and set a price target of ...

scPharmaceuticals Inc. ( NASDAQ: SCPH) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Nick Colangelo - Investor Relations John Tucker - Chief Executive Officer Steve Parsons - Senior ...

NYHA Class IV Approval: In August 2024, scPharmaceuticals announced that the U.S. Food and Drug Administration (FDA) granted approval for FUROSCIX, expanding the indication to include New York Heart ...

Nuwellis, Inc. (Nasdaq: NUWE), a medical device company focused on transforming the lives of people with fluid overload, today reported financial results ...

A new way of treating heart failure patients at Mercy Hospital Washington has been a major success, according to the doctor ...

Patients with heart failure are often advised to limit or avoid alcohol consumption altogether, as it can interfere with ...

Reimbursement rate to increase 397% per day effective January 1, 2025New rate expected to encourage adoption of ultrafiltration therapy in the ...

SeeMedX Inc. ("SeeMedX") today announced the submission of its 510(k) premarket notification to the U.S. Food and Drug ...

High blood pressure is linked to a myocardial anatomical change called LVH. Learn how to offset left ventricular thickening ...

Doctors often recommend that heart patients monitor their fluid intake to avoid overhydration. The key is to strike a balance between staying hydrated and preventing fluid overload. Dehydration can ...

Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients with fluid overload, is pleased to announce that University of Iowa Health Care Stead Family ...